XOMA Royalty Corporation
- Targets
- 5
- Filings
- 12
- Median premium
- 100%
- First filing
- Jun 27, 2025
- Latest filing
- Feb 9, 2026
Targets
| Company | Score before deal | Score now | Filings | Latest |
|---|---|---|---|---|
| Generation Bio Co. | — | — | 3 | Feb 9, 2026 |
| Mural Oncology plc | — | — | 2 | Sep 23, 2025 |
| LAVA Therapeutics NV | — | — | 3 | Sep 3, 2025 |
| HilleVax, Inc. | — | — | 2 | Aug 18, 2025 |
| Turnstone Biologics Corp. | — | — | 2 | Jul 11, 2025 |
Deal filings
| Filed | Company | Form | Price | Premium |
|---|---|---|---|---|
| Feb 9, 2026 | Generation Bio Co. | 8-K | — | — |
| Jan 9, 2026 | Generation Bio Co. | SC TO-T | — | — |
| Dec 15, 2025 | Generation Bio Co. | 8-K | — | — |
| Sep 23, 2025 | Mural Oncology plc | DEFM14A | $2.04 | 100% |
| Sep 12, 2025 | Mural Oncology plc | PREM14A | $2.24 | 125% |
| Sep 3, 2025 | LAVA Therapeutics NV | DEFM14A | $1.16 | 100% |
| Aug 22, 2025 | LAVA Therapeutics NV | PREM14A | $1.16 | 100% |
| Aug 18, 2025 | HilleVax, Inc. | SC TO-T | — | — |
| Aug 15, 2025 | LAVA Therapeutics NV | SC TO-T | — | — |
| Aug 4, 2025 | HilleVax, Inc. | 8-K | — | — |
| Jul 11, 2025 | Turnstone Biologics Corp. | SC TO-T | — | — |
| Jun 27, 2025 | Turnstone Biologics Corp. | 8-K | — | — |